Supplementary Materials from Preclinical Activity of SAR408701: A Novel Anti-CEACAM5–maytansinoid Antibody–drug Conjugate for the Treatment of CEACAM5-positive Epithelial TumorsStéphanie Decary,Pierre-François Berne,Céline Nicolazzi,Anne-Marie Lefebvre,Tarik Dabdoubi,Béatrice Cameron,Pierrick Rival,Catherine Devaud,Catherine Prades,Hervé Bouchard,Alhassan Cassé,Christophe Henry,Céline Amara,Claire Brillac,Paul Ferrari,Laetitia Maçon,Eric Lacoste,Cecile Combeau,Eric Beys,Souad Naimi, Carlos García-Echeverría,Jean-François Mayaux,Véronique Blanccrossref(2023)引用 0|浏览3暂无评分摘要Supplementary Materials更多查看译文AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要